Mabion Biologics at mBank Healthcare Days 2026
- Mabion has accepted an invitation from mBank Brokerage House to meet with investors and shareholders at the fourth edition of the mBank Healthcare Days conference.
- The event was attended by CEO Gregor Kawaletz and the company’s newly appointed Chief Financial Officer, Ilona Hinz.
Key discussions with the stock exchange
The conference brought together senior management from key publicly listed biotechnology and medical companies in Central and Eastern Europe. Mabion was recognized as one of the leading companies in the sector, included in the WIGmed index listed on the Warsaw Stock Exchange (GPW).
During the mBank Healthcare Days conference, Mabion’s leadership held a series of productive meetings with investors. Discussions covered the company’s current financial standing, near-term revenue outlook, and capital allocation strategy. Both executives presented a clear and confident picture of Mabion’s financial trajectory. On the business and operational side, conversations focused on Mabion’s growing project pipeline. Our experts had also the opportunity to engage in discussions with leading local and international institutional investors.
Prepared by:
Marketing Specialist